+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Cytotoxic Drugs Market 2020-2026

  • PDF Icon


  • May 2020
  • Region: Global
  • Orion Market Research Private Limited
  • ID: 5129774
Global Cytotoxic Drugs Market Size, Share & Trends Analysis Report, By Drug Class (Alkylating, Antimetabolites, Antitumor Antibiotics, Plant Alkaloids, and Others), By Application (Lung Cancer, Breast Cancer, Prostate Cancer, Cytotoxic, and Others) and Forecast, 2020-2026
The global cytotoxic market is estimated to witness sluggish growth during the forecast period. Increasing prevalence of cancer is primarily contributing to the growth of the market. There were 18.1 million new cancer incidences reported globally in 2018. Lung and female breast cancers are the major kinds of cancer globally in terms of the new cancer incidences in 2018. Each of these cancers accounted for nearly 2.1 million diagnoses in 2018, which is nearly 11.6% of the total new cancer incidences. Cytotoxic drugs are regarded as the first-line treatment for unresectable advanced non-small-cell lung carcinoma (NSCLC). These anti-cancer agents travel through the bloodstream and reach several parts of the body. Significant demand for chemotherapy has led the adoption of cytotoxic drugs as these agents act to destroy cancer cells. They treat cells that have broken away from the lung tumor and spread to other parts of the body.

Geographically, the market is classified into four major regions, including North America, Europe, Asia-Pacific, and Rest of the World (RoW). In 2019, North America is anticipated to hold a significant share in the market owing to the significant rise in new cancer incidences and rising demand for chemotherapy in the region. The presence of some crucial players such as Johnson & Johnson Services, Inc. and Pfizer Inc. is further contributing to the market growth in the region. Asia-Pacific is estimated to witness considerable growth during the forecast period owing to the rising cancer incidences and emerging awareness regarding cancer diseases in the region.

Some crucial players in the market include Pfizer Inc., Mylan N.V., Johnson & Johnson Services, Inc., F. Hoffman La-Roche AG, and Bristol Myers Squibb Co. Mergers and acquisitions, product launches, and partnerships and collaborations are considered as crucial strategies adopted by the market players. For instance, in February 2019, Eli Lilly and Company acquired Loxo Oncology, Inc. to widen the scope of oncology portfolio of Lilly into precision medicines with the addition of a pipeline of highly selective effective medications for patients suffering from genomically defined cancers. This will enable the company to target cancers that are caused by specific gene abnormalities.

Research Methodology

The market study of the global cytotoxic drugs market is incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook.

In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity in the reports.

Secondary Sources Include:
  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation:

1. Global Cytotoxic Drugs Market Research and Analysis by Drug Class
2. Global Cytotoxic Drugs Market Research and Analysis by Application

The Report Covers
  • Comprehensive research methodology of the global cytotoxic drugs market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global cytotoxic drugs market.
  • Insights about market determinants, which are stimulating the global cytotoxic drugs market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Pipeline Analysis
2.4. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Pfizer Inc. Overview Financial Analysis SWOT Analysis Recent Developments
3.3.2. Mylan N.V. Overview Financial Analysis SWOT Analysis Recent Developments
3.3.3. Johnson & Johnson Services, Inc. Overview Financial Analysis SWOT Analysis Recent Developments
3.3.4. F. Hoffman La-Roche AG Overview Financial Analysis SWOT Analysis Recent Developments
3.3.5. Bristol Myers Squibb Co. Overview Financial Analysis SWOT Analysis Recent Developments
4. Market Determinants
4.1 Motivators
4.2 Restraints
4.3 Opportunities
5. Market Segmentation
5.1. Global Cytotoxic Drugs Market by Drug Class
5.1.1. Alkylating
5.1.2. Antimetabolites
5.1.3. Antitumor Antibiotics
5.1.4. Plant Alkaloids
5.1.5. Others
5.2. Global Cytotoxic Drugs Market by Application
5.2.1. Lung Cancer
5.2.2. Breast Cancer
5.2.3. Prostate Cancer
5.2.4. Pancreatic Cancer
5.2.5. Others
6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. AbbVie Inc.
7.2. Amgen Inc.
7.3. Bayer AG
7.4. Bristol Myers Squibb Co.
7.5. Cipla Ltd.
7.6. Daiichi Sankyo Company, Ltd.
7.7. Eli Lilly and Co.
7.8. F. Hoffman La-Roche AG
7.9. Fresenius SE & Co. KGaA
7.10. GlaxoSmithKline plc
7.11. Johnson & Johnson Services, Inc.
7.12. Lonza Group Ltd.
7.13. Lupin Ltd.
7.14. Merck & Co., Inc.
7.15. Mylan N.V.
7.16. Novartis International AG
7.17. Pfizer Inc.
7.18. Sanofi S.A.
7.19. Sun Pharmaceutical Industries Ltd.
7.20. Teva Pharmaceutical Industries Ltd.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • AbbVie Inc.
  • Amgen Inc.
  • Bayer AG
  • Bristol Myers Squibb Co.
  • Cipla Ltd.
  • Daiichi Sankyo Company, Ltd.
  • Eli Lilly and Co.
  • F. Hoffman La-Roche AG
  • Fresenius SE & Co. KGaA
  • GlaxoSmithKline plc
  • Johnson & Johnson Services, Inc.
  • Lonza Group Ltd.
  • Lupin Ltd.
  • Merck & Co., Inc.
  • Mylan N.V.
  • Novartis International AG
  • Pfizer Inc.
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.